Data compiled by Redley Lamar · ChainSifter Intelligence
2Suppliers
6Customers
2Debt Items
0Related Chains
Source-Backed Evidence Depth
Pomdoctor Limited (POM) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
11Total relationships
2Distinct source URLs
7High confidence
0.793Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Pomdoctor Limited Suppliers
Ticker
Name
Confidence
Evidence
DONGGUAN-CHAOYANG-PHARMACEUTICAL-CO-LTD
DONGGUAN-CHAOYANG-PHARMACEUTICAL-CO-LTD
92%
For the year ended December 31, 2025, two suppliers, namely Dongguan Chaoyang Pharmaceutical Co., Ltd and Guangzhou Guoying Pharmaceutical Co., Ltd., collectively accounted for 63.4% of our total pur…
GUANGZHOU-GUOYING-PHARMACEUTICAL-CO-LTD
GUANGZHOU-GUOYING-PHARMACEUTICAL-CO-LTD
92%
For the year ended December 31, 2025, two suppliers, namely Dongguan Chaoyang Pharmaceutical Co., Ltd and Guangzhou Guoying Pharmaceutical Co., Ltd., collectively accounted for 63.4% of our total pur…
Pomdoctor Limited Customers
Ticker
Name
Confidence
Evidence
JIANGSU-HAOSOH-PHARMACEUTICAL-GROUP-CO-LTD
JIANGSU-HAOSOH-PHARMACEUTICAL-GROUP-CO-LTD
85%
lity reasons. For other products under direct sales, we generally allow customers to return unused goods within seven days and to exchange defective goods. In respect of products of which we manage i…
PHARMACEUTICAL-CO-LTD
PHARMACEUTICAL-CO-LTD
85%
yang Pharmaceutical Co., Ltd., accounted for 39.1% of our total purchases. For the year ended December 31, 2025, two suppliers, namely Dongguan Chaoyang Pharmaceutical Co., Ltd. and Guangzhou Guoying…
CHAOYANG-PHARMACEUTICAL-CO-LTD
CHAOYANG-PHARMACEUTICAL-CO-LTD
62%
ngguan Chaoyang Pharmaceutical Co., Ltd. and Guangzhou Suize Pharmaceutical Co., Ltd., collectively accounted for 44.0% of our total purchases. For the year ended December 31, 2024, one supplier, nam…
CO-LTD
CO-LTD
62%
utical Co., Ltd., collectively accounted for 44.0% of our total purchases. For the year ended December 31, 2024, one supplier, namely Dongguan Chaoyang Pharmaceutical Co., Ltd., accounted for 39.1% o…
GUANGZHOU-QILEKANG-PHARMACEUTICAL-CHAIN-CO-LTD
GUANGZHOU-QILEKANG-PHARMACEUTICAL-CHAIN-CO-LTD
62%
ily attributable to our net loss of RMB36.9 million, as adjusted by the reconciliation of net loss to net cash used in operating activities, which primarily comprised (i) changes in expected credit l…
XIAMEN-AMOYTOP-BIOTECH-CO-LTD-SHENYANG-SINQI-PHA
XIAMEN-AMOYTOP-BIOTECH-CO-LTD-SHENYANG-SINQI-PHA
62%
lity reasons. For other products under direct sales, we generally allow customers to return unused goods within seven days and to exchange defective goods. In respect of products of which we manage i…
Pomdoctor Limited Debt Obligations
Instrument
Description
Confidence
Evidence
POM-DEBT-60871
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
POM-DEBT
Debt stack $19.3M
90%
Market cache reports total debt of $19.3M.
Pomdoctor Limited Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Pomdoctor Limited.
Pomdoctor Limited Ownership
Holder
Name
Confidence
Evidence
POM-OWNER-CITADEL-ADVISORS-LLC
CITADEL ADVISORS LLC
90%
13F overlay lists CITADEL ADVISORS LLC as top holder; 10 tracked holders.
Pomdoctor Limited Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
